Therapeutic exosomes and biomaterials platform for tissue regeneration
Pandorum develops a proprietary tissue-engineering platform combining clinical-grade exosomes with biomaterials to regenerate damaged tissues like cornea, liver, and lung. The tech stack—Python, TensorFlow, PyTorch, ImageJ, MATLAB—reflects a research-heavy operation focused on microscopy analysis and ML-driven biomarker discovery rather than software infrastructure. The organization is weighted toward senior research talent (6 of 9 open roles), with parallel hiring in operations and regulatory affairs, signaling the company's shift from discovery toward preclinical GLP studies and IND-enabling programs.
Notable leadership hires: Head of Operations
Pandorum is a US–India biotechnology company headquartered in Bangalore, founded in 2011, operating at 11–50 employees. The platform combines therapeutic exosomes derived from human stem cells with tissue-mimetic biomaterials to address regeneration of organs with unmet clinical needs. Development is supported by partnerships with medical institutions including Northwestern Medicine, Medical University of South Carolina, and Dr. Shroff's Charity Eye Hospital. Current work spans biomaterials research, microscopy-based image analysis, polymeric scaffold fabrication, and protocol development for preclinical and IND-enabling studies. The company operates across research, healthcare, and operations functions with a senior-dominated team.
Biomaterials research for tissue regeneration, microscopy image analysis, ML biomarker discovery, polymeric scaffold fabrication, and SAP development for preclinical GLP studies and IND-enabling programs targeting cornea, liver, and lung regeneration.
Python, TensorFlow, PyTorch, MATLAB, ImageJ, OpenCV, scikit-learn, scikit-image, R, GitHub, Linux, and visualization tools including Tableau, Plotly, and ggplot2 for microscopy analysis and biomarker discovery.
Other companies in the same industry, closest in size